Acquisition by Hammacher Alex of 19197 shares of Vaccitech PLC subject to Rule 16b-3

VACCDelisted Stock  USD 2.23  0.04  1.83%   
About 54% of Vaccibody's shareholders are presently thinking to get in. The analysis of current outlook of investing in Vaccibody As suggests that some traders are interested regarding Vaccibody's prospects. The current market sentiment, together with Vaccibody's historical and current headlines, can help investors time the market. In addition, many technical investors use Vaccibody As stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Vaccitech Plc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at investing.com
Investing News at Macroaxis
  
Vaccitech insider trading alert for grant of share option right to buy by Hammacher Alex, the corporate stakeholder, on 12th of May 2023. This event was filed by Vaccitech Plc with SEC on 2023-05-12. Statement of changes in beneficial ownership - SEC Form 4

Vaccibody Fundamental Analysis

We analyze Vaccibody's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaccibody using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaccibody based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Vaccibody is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Vaccibody As Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vaccibody stock to make a market-neutral strategy. Peer analysis of Vaccibody could also be used in its relative valuation, which is a method of valuing Vaccibody by comparing valuation metrics with similar companies.

Peers

Vaccibody Related Equities

MNOVMediciNova   14.98   
0%
100.0%
VORVor Biopharma   4.82   
0%
32.0%
DSGNDesign Therapeutics   4.67   
0%
31.0%
CTMXCytomX Therapeutics   2.83   
0%
18.0%
TILInstil Bio   2.49   
0%
16.0%
TYRATyra Biosciences   1.15   
0%
7.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
4.0%
STOKStoke Therapeutics   0.33   
2.0%
0%
SPROSpero Therapeutics   0.88   
5.0%
0%
ACETAdicet Bio   0.88   
5.0%
0%
ACHLAchilles Therapeutics   0.93   
6.0%
0%
ASMBAssembly Biosciences   1.70   
11.0%
0%
CGEMCullinan Oncology   2.08   
13.0%
0%
THRDThird Harmonic   2.66   
17.0%
0%
EWTXEdgewise Therapeutics   4.42   
29.0%
0%
CSBRChampions Oncology   4.65   
31.0%
0%
CCCCC4 Therapeutics   5.49   
36.0%
0%
MOLNMolecular Partners   7.22   
48.0%
0%
RVMDRevolution Medicines   10.46   
69.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Vaccibody Stock

If you are still planning to invest in Vaccibody As check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccibody's history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stocks Directory
Find actively traded stocks across global markets